CC-3052 - CAS 216884-02-5
Catalog number:
216884-02-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H21NO5
Molecular Weight:
355.38
COA:
Inquire
Targets:
HIV Protease
Description:
CC-3052, a thalidomide analogue, reduces persistent activation of the TNF-α system in HIV without markedly impairing neutrophil viability.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Appearance:
Solid powder
Synonyms:
methyl (2R)-2-(3,4-dimethoxyphenyl)-3-(3-oxo-1H-isoindol-2-yl)propanoate; CC 3052; CC-3052
Solubility:
water-soluble
MSDS:
Inquire
InChIKey:
XUDYTJVYZTVYGI-INIZCTEOSA-N
InChI:
1S/C20H21NO5/c1-24-17-9-8-13(10-18(17)25-2)16(20(23)26-3)12-21-11-14-6-4-5-7-15(14)19(21)22/h4-10,16H,11-12H2,1-3H3/t16-/m0/s1
Canonical SMILES:
COC1=C(C=C(C=C1)C(CN2CC3=CC=CC=C3C2=O)C(=O)OC)OC
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Protease Products


CC-3052
(CAS: 216884-02-5)

CC-3052, a thalidomide analogue, reduces persistent activation of the TNF-α system in HIV without markedly impairing neutrophil viability.

DPC-681
(CAS: 284661-68-3)

DPC-681, sulfonamide derivatives, is an extremely potent and selective inhibitor of HIV protease. IC90s: wild-type HIV-1=4-40 nM

PD 099560
(CAS: 155758-74-0)

PD 099560, a benzopyran derivative, has been found to be a HIV-1 protease inhibitor that could be significant in HIV studies.

BMS-187071
(CAS: 161302-39-2)

BMS-187071 has been found to be a HIV protease inhibitor that was once studied against HIV by Bristol-Myers Squibb.

MK-8718 HCl
(CAS: 1582732-29-3)

The hydrochloride salt form of MK-8718 which has been found to be a HIV protease inhibitor and could be studied in HIV research.

CGP-75355
(CAS: 191594-64-6)

CGP-75355 is an HIV Protease inhibitor (EC50= 0.7 nM).

CI-1029
(CAS: 207736-05-8)

CI-1029 is a nonpeptidic inhibitor of HIV protease, potenat against mutant HIV protease and resistant HIV strains.

CAS 138483-63-3 L-689502

L-689502
(CAS: 138483-63-3)

A potent inhibitor of HIV-l protease (IC50= 1 nM)

BMS-186318
(CAS: 161302-40-5)

BMS-186318 has been found to be a HIV protease inhibitor that was once studied against HIV by Bristol-Myers Squibb.

MK-8718
(CAS: 1582729-24-5)

MK-8718 has been found to be a HIV protease inhibitor and could be studied in HIV research.

Quick Inquiry

Verification code

Featured Items